This report contains market size and forecasts of Iguratimod in global, including the following market information:
Global Iguratimod Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Iguratimod Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Iguratimod companies in 2021 (%)
The global Iguratimod market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
14 Pcs/Box Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iguratimod include Simcere Pharmaceutical, Toyama Chemical and Eisai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Iguratimod manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iguratimod Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Iguratimod Market Segment Percentages, by Type, 2021 (%)
14 Pcs/Box
100 Pcs/Box
Global Iguratimod Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Iguratimod Market Segment Percentages, by Application, 2021 (%)
Antirheumatic
Immunoregulation
Other
Global Iguratimod Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Iguratimod Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Iguratimod revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Iguratimod revenues share in global market, 2021 (%)
Key companies Iguratimod sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Iguratimod sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Simcere Pharmaceutical
Toyama Chemical
Eisai